176 related articles for article (PubMed ID: 31278792)
1. The changing epidemiology of community-acquired pneumonia: nationwide register-based study in Sweden.
Naucler P; Henriques-Normark B; Hedlund J; Galanis I; Granath F; Örtqvist Å
J Intern Med; 2019 Dec; 286(6):689-701. PubMed ID: 31278792
[TBL] [Abstract][Full Text] [Related]
2. Impact of infant pneumococcal conjugate vaccination on community acquired pneumonia hospitalization in all ages in the Netherlands.
van Deursen AMM; Schurink-Van't Klooster TM; Man WH; van de Kassteele J; van Gageldonk-Lafeber AB; Bruijning-Verhagen PCJL; de Melker HE; Sanders EAM; Knol MJ
Vaccine; 2017 Dec; 35(51):7107-7113. PubMed ID: 29146381
[TBL] [Abstract][Full Text] [Related]
3. The impact of pneumococcal conjugate vaccine on community-acquired pneumonia hospitalizations in children with comorbidity.
Sterky E; Bennet R; Lindstrand A; Eriksson M; Nilsson A
Eur J Pediatr; 2017 Mar; 176(3):337-342. PubMed ID: 28070670
[TBL] [Abstract][Full Text] [Related]
4. 13-Valent vaccine serotype pneumococcal community acquired pneumonia in adults in high clinical risk groups.
Daniel P; Rodrigo C; Bewick T; Sheppard C; Greenwood S; McKeever TM; Trotter C; Lim WS
Vaccine; 2018 Mar; 36(12):1614-1620. PubMed ID: 29439865
[TBL] [Abstract][Full Text] [Related]
5. Impact of PCV7/PCV13 introduction on community-acquired alveolar pneumonia in children <5 years.
Greenberg D; Givon-Lavi N; Ben-Shimol S; Ziv JB; Dagan R
Vaccine; 2015 Aug; 33(36):4623-9. PubMed ID: 26116251
[TBL] [Abstract][Full Text] [Related]
6. Changes in hospitalizations for pneumonia after universal vaccination with pneumococcal conjugate vaccines 7/13 valent and haemophilus influenzae type b conjugate vaccine in a Pediatric Referral Hospital in Uruguay.
Pírez MC; Algorta G; Chamorro F; Romero C; Varela A; Cedres A; Giachetto G; Montano A
Pediatr Infect Dis J; 2014 Jul; 33(7):753-9. PubMed ID: 24492286
[TBL] [Abstract][Full Text] [Related]
7. Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands.
Vestjens SMT; Wagenvoort GHJ; Grutters JC; Meek B; Aldenkamp AF; Vlaminckx BJM; Bos WJW; Rijkers GT; van de Garde EMW
Vaccine; 2017 Jul; 35(33):4112-4118. PubMed ID: 28668570
[TBL] [Abstract][Full Text] [Related]
8. Burden of hospitalized childhood community-acquired pneumonia: A retrospective cross-sectional study in Vietnam, Malaysia, Indonesia and the Republic of Korea.
Tan KK; Dang DA; Kim KH; Kartasasmita C; Kim HM; Zhang XH; Shafi F; Yu TW; Ledesma E; Meyer N
Hum Vaccin Immunother; 2018 Jan; 14(1):95-105. PubMed ID: 29125809
[TBL] [Abstract][Full Text] [Related]
9. Clinical features of adults with seven-valent-conjugated-vaccine-serotype pneumococcal pneumonia.
Rodrigo C; Bewick T; Sheppard C; Greenwood S; Trotter C; Slack M; George R; Lim WS
Vaccine; 2014 Mar; 32(13):1460-5. PubMed ID: 24508039
[TBL] [Abstract][Full Text] [Related]
10. Influence of pneumococcal vaccination on the hospitalization of healthy pediatric patients due to typical Community-Acquired Pneumonia.
Valdivielso Martínez AI; Ramos Fernández JM; Pérez Frías J; Moreno Pérez D
Int J Infect Dis; 2020 Sep; 98():194-199. PubMed ID: 32553718
[TBL] [Abstract][Full Text] [Related]
11. The impact of heptavalent pneumococcal conjugate vaccine on the incidence of childhood community-acquired pneumonia and bacteriologically confirmed pneumococcal pneumonia in Japan.
Naito S; Tanaka J; Nagashima K; Chang B; Hishiki H; Takahashi Y; Oikawa J; Nagasawa K; Shimojo N; Ishiwada N
Epidemiol Infect; 2016 Feb; 144(3):494-506. PubMed ID: 26122538
[TBL] [Abstract][Full Text] [Related]
12. Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults.
Nelson JC; Jackson M; Yu O; Whitney CG; Bounds L; Bittner R; Zavitkovsky A; Jackson LA
Vaccine; 2008 Sep; 26(38):4947-54. PubMed ID: 18662735
[TBL] [Abstract][Full Text] [Related]
13. Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review.
Torres A; Cillóniz C; Blasi F; Chalmers JD; Gaillat J; Dartois N; Schmitt HJ; Welte T
Respir Med; 2018 Apr; 137():6-13. PubMed ID: 29605214
[TBL] [Abstract][Full Text] [Related]
14. Pneumococcal vaccines and the prevention of community-acquired pneumonia.
Esposito S; Principi N
Pulm Pharmacol Ther; 2015 Jun; 32():124-9. PubMed ID: 24607597
[TBL] [Abstract][Full Text] [Related]
15. Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience.
Baldo V; Cocchio S; Gallo T; Furlan P; Romor P; Bertoncello C; Buja A; Baldovin T
PLoS One; 2016; 11(11):e0166637. PubMed ID: 27846277
[TBL] [Abstract][Full Text] [Related]
16. [Prevention of Streptococcus pneumoniae (pneumococcal) infections in adults].
Ludwig E; Mészner Z;
Orv Hetil; 2014 Dec; 155(50):1996-2004. PubMed ID: 25481502
[TBL] [Abstract][Full Text] [Related]
17. Exploratory efficacy endpoints in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA).
Webber C; Patton M; Patterson S; Schmoele-Thoma B; Huijts SM; Bonten MJ;
Vaccine; 2017 Mar; 35(9):1266-1272. PubMed ID: 28173960
[TBL] [Abstract][Full Text] [Related]
18. Pneumonia hospitalisations in Scotland following the introduction of pneumococcal conjugate vaccination in young children.
Nair H; Watts AT; Williams LJ; Omer SB; Simpson CR; Willocks LJ; Cameron JC; Campbell H
BMC Infect Dis; 2016 Aug; 16():390. PubMed ID: 27506837
[TBL] [Abstract][Full Text] [Related]
19. Early impact of 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in children.
Angoulvant F; Levy C; Grimprel E; Varon E; Lorrot M; Biscardi S; Minodier P; Dommergues MA; Hees L; Gillet Y; Craiu I; Zenkhri F; Dubos F; Guen CG; Launay E; Martinot A; Cohen R
Clin Infect Dis; 2014 Apr; 58(7):918-24. PubMed ID: 24532543
[TBL] [Abstract][Full Text] [Related]
20. Decrease in the incidence and in hospital mortality of community-acquired pneumonia among children in Spain (2001-2014).
Jimenez Trujillo I; Lopez de Andres A; Hernandez-Barrera V; Martinez-Huedo MA; de Miguel-Diez J; Jimenez-Garcia R
Vaccine; 2017 Jun; 35(30):3733-3740. PubMed ID: 28558982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
